There are currently 5-10 million people on a branded GLP-1 medication, but there is an estimated 50-60 million who are clinically eligible to receive Wegovy and have insurance coverage for it, and of those, millions could purchase it for a copay of less than $100/month
5985-5995, Oct
Lets dive into the science behind GLP-1s, trends and demands employers are seeing for these drugs, and how you can ensure youve got the right building blocks for GLP-1 success
GLP-1R populations in the nucleus accumbens (ACBs), paraventricular nucleus (PVH), lateral hypothalamus (LHA), and ventral tegmental area (VTA) are involved in food choice, reward, and taste aversion [40]
Your protocol arrives discreetly at your door, prepared by a state-licensed 503A compounding pharmacy